SEREVENT Safety Questions, SEREVENT Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about SEREVENT. Our extensive database of SEREVENT adverse events and SEREVENT warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about SEREVENT

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




SEREVENT Safety Reports

Total SEREVENT reports: 146.
SEREVENT FDA safety alerts: 2003 2005 .
Reported deaths: 16    Reported hospitalizations: 30.
Take SEREVENT Side Effects Survey or Share Your SEREVENT Story. Read More Here.

Showing 1-75 of 146 Next >

Pharmacist from CANADA reported SEREVENT problem on Oct 19, 2006. Male patient, 83 years of age, weighting 145.3 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma, dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with SYNTHROID, ATENOLOL, LACTULOSE, PAROXETINE, ADALAT. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2003. Female patient, 79 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, dyspnoea, respiratory disorder. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, ATROVENT, LEVOTHYROXINE, RANITIDINE, LIPITOR, MORPHINE, SINGULAIR, SPIRIVA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Dec 08, 2003. Female patient, 62 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: aphonia, cough. SEREVENT dosage: unknown. During the same period patient was treated with FLOVENT, SINGULAIR, FLONASE. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2004. Female patient, 65 years of age, weighting 143.3 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Sept 02, 2005. Female patient, 69 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort. SEREVENT dosage: unknown. During the same period patient was treated with AVAPRO, GLUCOPHAGE, COREG. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 09, 2005. Female patient was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: gait disturbance. SEREVENT dosage: unknown. During the same period patient was treated with FLOVENT, ALBUTEROL, ACCOLATE, THEOPHYLLINE, NEBULIZER. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Sept 19, 2005. Female patient, 63 years of age, was diagnosed with emphysema and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, LIPITOR, ALTACE, HYDROCHLOROTHIAZIDE. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2005. Female patient, 77 years of age, was diagnosed with lung disorder and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, heart rate increased. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, ISOSORBIDE, ADEPRIL, ARIMIDEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Oct 10, 2005. Female patient, 75 years of age, was diagnosed with bronchitis and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with VALIUM, DILANTIN. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2005. Female patient, 68 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with COMBIVENT, KEPPRA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Oct 28, 2005. Female patient, 79 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: cough. SEREVENT dosage: unknown. During the same period patient was treated with LOTENSIN, WARFARIN. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2005. Female patient, 70 years of age, weighting 146.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with FLONASE, NEURONTIN, SINGULAIR, FOSAMAX, AEROBID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Nov 09, 2005. Male patient, 44 years of age, weighting 160.3 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, dizziness, feeling jittery, headache, nervousness, palpitations. SEREVENT dosage: unknown. During the same period patient was treated with SINGULAIR, FLOVENT, BENADRYL, SUDAFED. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2005. Male patient, 59 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with FLOVENT, NORVASC, ENALAPRIL MALEATE, ZOLOFT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Nov 18, 2005. Male patient, 74 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with AEROBID, HYDROCHLOROTHIAZIDE, POTASSIUM ACETATE, OCUVITE, ALBUTEROL. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 22, 2005. Male patient, 44 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: wheezing. SEREVENT dosage: unknown. During the same period patient was treated with BECONASE AQ, FLOVENT, SYNTHROID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Dec 02, 2005. Female patient, 82 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with PULMICORT, SYNTHROID. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2005. Male patient, child 9 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: agitation, feeling abnormal, headache, hypokalaemia, overdose, supraventricular tachycardia. SEREVENT dosage: unknown. During the same period patient was treated with SINGULAIR, FLOVENT, MAXAIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Dec 07, 2005. Male patient, 67 years of age, was diagnosed with respiratory disorder and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dysgeusia, dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with SPIRIVA, ALBUTEROL. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Female patient, 70 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: alopecia. SEREVENT dosage: unknown. During the same period patient was treated with XOPENEX, ALBUTEROL, CHROMELIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Dec 21, 2005. Female patient, 61 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort, cough, nasal congestion, pharyngolaryngeal pain, respiratory disorder, wheezing. SEREVENT dosage: unknown. During the same period patient was treated with ALUPENT. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2005. Female patient, 84 years of age, was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Jan 04, 2006. Female patient, 69 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: epistaxis. SEREVENT dosage: unknown. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2006. Female patient, 65 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: cough, prescribed overdose. SEREVENT dosage: unknown. During the same period patient was treated with LISINOPRIL, FLOVENT, LEVOXYL, CALCIUM GLUCONATE, VITAMINS, NEURONTIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Jan 09, 2006. Male patient, 64 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort. SEREVENT dosage: unknown. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2006. Female patient, 59 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: depression, dyspnoea, muscle spasms, musculoskeletal discomfort. SEREVENT dosage: unknown. During the same period patient was treated with VENTOLIN, NORVASK, XALATAN, OPTICROM, INTAL, SINGULAIR, ASPIRIN, SKELAXIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Jan 11, 2006. Female patient, 53 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: oral infection. SEREVENT dosage: unknown. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2006. Female patient, 54 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: respiratory tract infection viral. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, SPIRIVA, VITAMINS, FOSAMAX, LEVOXYL, THEOPHYLLINE, ANTIBIOTICS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Jan 30, 2006. Female patient, 92 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort. SEREVENT dosage: unknown. During the same period patient was treated with SPIRIVA, ATROVENT. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2006. Female patient, 78 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma, peak expiratory flow rate decreased. SEREVENT dosage: unknown. During the same period patient was treated with PULMICORT, ALBUTEROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Feb 16, 2006. Female patient, 69 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: candidiasis. SEREVENT dosage: unknown. During the same period patient was treated with ASMACORT, MAXAIR, LORAZEPAM, POTASSIUM ACETATE, ZANTAC, HYDROCHLOROTHIAZIDE, PREMARIN, LISINOPRIL. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Male patient, 70 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: respiratory disorder, wheezing. SEREVENT dosage: unknown. During the same period patient was treated with LOVASTATIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Feb 23, 2006. Male patient, 55 years of age, weighting 178.4 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, tongue ulceration. SEREVENT dosage: unknown. During the same period patient was treated with SINGULAIR. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient, 15 years of age, was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: accidental overdose. SEREVENT dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Mar 23, 2006. Male patient, 51 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma. SEREVENT dosage: unknown. Patient was hospitalized. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 07, 2006. Female patient was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: saliva discolouration, tongue discolouration. SEREVENT dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Apr 12, 2006. Female patient was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2006. Female patient, 58 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: alopecia. SEREVENT dosage: unknown. During the same period patient was treated with QVAR, ALUPENT, ALBUTEROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on May 18, 2006. Male patient, 63 years of age, was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with ATROVENT, FLOVENT, POTASSIUM ACETATE, ATACAND, BENAZEPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2006. Female patient, 87 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: oral pain, pharyngolaryngeal pain. SEREVENT dosage: unknown. During the same period patient was treated with COMBIVENT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on May 30, 2006. Male patient, 81 years of age, weighting 178.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: anorexia, arthralgia, dyspnoea, fatigue, temperature intolerance. SEREVENT dosage: unknown. During the same period patient was treated with FLOVENT, COMBIVENT, PREVACID. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2006. Female patient, 83 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: abdominal distension, diarrhoea, gingival swelling, nausea, oral pain. SEREVENT dosage: unknown. During the same period patient was treated with CLINDAMYCIN. Patient recovered.

Pharmacist from UNITED STATES reported SEREVENT problem on June 06, 2006. Male patient, 64 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: cough. SEREVENT dosage: unknown. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Female patient was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, IPRATROPIUM BROMIDE, FLUTICASONE NASAL SPRAY, ASTELIN, ZYRTEC, PULMICORT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on July 18, 2006. Female patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: abdominal distension, chest discomfort, chest pain, dyspnoea. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, LASIX, ALPRAZOLAM, SEROQUEL. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Female patient, 46 years of age, was diagnosed with restrictive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: paraesthesia oral. SEREVENT dosage: unknown. During the same period patient was treated with VERELAN PM, THEOPHYLLINE, TORSEMIDE, CLARINEX, POTASSIUM ACETATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on July 27, 2006. Female patient, 65 years of age, was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: wheezing. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, FLONASE, NASONEX, ALLEGRA, GLUCOVANCE, NEXIUM, VITAMINS. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2006. Female patient, 88 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dysgeusia. SEREVENT dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Aug 10, 2006. Female patient, 79 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma. SEREVENT dosage: unknown. During the same period patient was treated with MAXAIR, FLOVENT, ATROVENT. Patient was hospitalized. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2005. Male patient, 17 years of age, weighting 209.4 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, aggression, breath sounds abnormal, cardio-respiratory arrest, dyspnoea, flushing, gastrointestinal haemorrhage, hepatosplenomegaly. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, TAGAMET, FLOVENT, FLONASE. Patient died on 10/23/1999.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Oct 25, 2006. Female patient, 60 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, loss of consciousness, pulmonary function test decreased. SEREVENT dosage: unknown. During the same period patient was treated with PULMICORT, ALBUTEROL, NEBULIZER, INHALER, XOPENEX, OXYGEN. Patient recovered.

SEREVENT problem was reported by a Physician from JAPAN on Oct 20, 2006. Male patient, 75 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma. SEREVENT dosage: unknown. During the same period patient was treated with FLUTIDE, QVAR, CLARITHROMYCIN, MUCODYNE, THEOLONG, BAKUMONDO, DASEN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Oct 25, 2006. Female patient, 60 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, loss of consciousness, pulmonary function test decreased. SEREVENT dosage: unknown. During the same period patient was treated with PULMICORT, ALBUTEROL, NEBULIZER, INHALER, XOPENEX, OXYGEN. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient was diagnosed with chronic obstructive pulmonary disease, asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hepatic enzyme increased, weight increased. SEREVENT dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, ALBUTEROL, SPIRIVA. Patient recovered.

Physician from JAPAN reported SEREVENT problem on Nov 10, 2006. Male patient was diagnosed with asthma and was treated with SEREVENT. SEREVENT dosage: unknown. During the same period patient was treated with FLUTIDE, MEPTIN. Patient died on 11/09/2006.

SEREVENT problem was reported by a Pharmacist from CANADA on Nov 17, 2006. Male patient, 69 years of age, was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: adverse event, condition aggravated. SEREVENT dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from CANADA reported SEREVENT problem on Nov 17, 2006. Male patient, 69 years of age, was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: adverse event. SEREVENT dosage: unknown. Patient was hospitalized. Patient recovered.

SEREVENT problem was reported by a Pharmacist from JAPAN on Oct 02, 2006. Male patient, 62 years of age, was diagnosed with asthma, hypertension, angina pectoris, abdominal distension, productive cough and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma, bronchitis, pruritus. SEREVENT dosage: unknown. During the same period patient was treated with FLUTIDE, NORVASC, SIGMART, NITOROL, QVAR. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported SEREVENT problem on Nov 10, 2006. Male patient was diagnosed with asthma and was treated with SEREVENT. SEREVENT dosage: unknown. During the same period patient was treated with FLUTIDE, MEPTIN. Patient died on 11/09/2006.

SEREVENT problem was reported by a Pharmacist from CANADA on Nov 17, 2006. Male patient, 69 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: respiratory disorder. SEREVENT dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, FLOVENT, MICRO, TERAZOSIN, SPIRIVA, NORVASC, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Pharmacist from FRANCE reported SEREVENT problem on Nov 17, 2006. Male patient, 34 years of age, weighting 198.4 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, glycosylated haemoglobin increased, weight increased. SEREVENT dosage: unknown. During the same period patient was treated with BECOTIDE, VENTOLIN. Patient recovered.

SEREVENT problem was reported by a Pharmacist from JAPAN on Oct 02, 2006. Male patient, 62 years of age, was diagnosed with asthma, hypertension, angina pectoris, abdominal distension, productive cough and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma, bronchitis, pruritus. SEREVENT dosage: unknown. During the same period patient was treated with FLUTIDE, NORVASC, SIGMART, NITOROL, CHINESE HERBAL MEDICINE, QVAR. Patient was hospitalized. Patient recovered.

Pharmacist from CANADA reported SEREVENT problem on Nov 17, 2006. Male patient, 69 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, respiratory disorder. SEREVENT dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, FLOVENT, MICRO, TERAZOSIN, SPIRIVA, NORVASC, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Female patient, 63 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: respiratory distress. SEREVENT dosage: unknown. During the same period patient was treated with ZYRTEC, ASTELIN, QVAR, NORVASC, BACLOFEN, AMANTADINE, FLONASE. Patient recovered.

Consumer or non-health professional from CANADA reported SEREVENT problem on Dec 20, 2006. Female patient, 37 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma, hypersensitivity, infection. SEREVENT dosage: unknown. During the same period patient was treated with FLOVENT, ADVAIR DISKUS, VENTOLIN, QVAR. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Male patient, 65 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: cough, lobar pneumonia, wheezing. SEREVENT dosage: unknown. During the same period patient was treated with PREDNISONE, AVELOX, DUONEB, ALBUTEROL, FLOVENT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Aug 08, 2007. Female patient, 51 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, malaise, myocardial infarction, pain. SEREVENT dosage: unknown. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Male patient, 17 years of age, weighting 209.4 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, aggression, breath sounds abnormal, cardio-respiratory arrest, dyspnoea, flushing, gastrointestinal haemorrhage, hepatosplenomegaly. SEREVENT dosage: unknown. During the same period patient was treated with ALBUTEROL, TAGAMET, FLOVENT, FLONASE. Patient died on 10/23/1999.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Sept 10, 2007. Male patient was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: asthma, dyspnoea, fatigue, peak expiratory flow rate decreased, sleep disorder. SEREVENT dosage: unknown. During the same period patient was treated with PREDNISONE, SPIRIVA. Patient recovered.

SEREVENT problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Male patient, 65 years of age, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: cough, lobar pneumonia, wheezing. SEREVENT dosage: unknown. During the same period patient was treated with PREDNISONE, AVELOX, DUONEB, ALBUTEROL, FLOVENT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SEREVENT problem on Sept 20, 2007. Female patient, weighting 145.3 lb, was diagnosed with asthma and was treated with SEREVENT. After drug was administered, patient experienced the following problems/side effects: anoxic encephalopathy, anxiety, apnoea, asphyxia, asthma, bronchial hyperreactivity, bronchospasm, cardio-respiratory arrest, coma. SEREVENT dosage: unknown. During the same period patient was treated with FLOVENT, ALBUTEROL, MAGNESIUM SULPHATE, VANCERIL, PREDNISONE, ACCOLATE, CITRACAL. Patient was hospitalized. Patient died on 04/15/2005.

Showing 1-75 of 146 Next >

Ask Our Patient Community about SEREVENT

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant